Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Supplemental appropriations could boost FDA funding: Legislation scheduled for markup by the Senate Appropriations Committee May 15 would give FDA an extra $275 million, bringing the agency's total funding increase in 2008 to $425 million. The boost, sponsored by Sen. Herb Kohl, D-Wis., is part of a broader emergency supplemental appropriations bill. It would direct $125 million for food safety activities, $100 million to medical product and drug safety activities, $40 million to modernizing FDA science and the FDA workforce, and $10 million to upgrade FDA facilities outside Washington, D.C. Among other uses, new funding could allow FDA to open overseas offices in two more countries, launch a pediatric devices safety initiative and conduct more medical product inspections, Kohl says

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026102

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel